Metabolic and cellular bases of sphingolipidoses

Biochemical Society Transactions

Volumn 41, Issue 6, 2013, Pages 1562-1568

  Sandhoff, Konrad ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Endocytosis; Intraendolysosomal vesicle; Lipid transfer protein; Sphingolipid; Sphingolipidosis

Indexed keywords

ESCRT PROTEIN; GANGLIOSIDE GM2; LIPID BINDING PROTEIN; MEMBRANE LIPID; SPHINGOLIPID; SPHINGOLIPID ACTIVATOR PROTEIN; SPHINGOLIPID ACTIVATOR PROTEIN 1; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME GLYCOSYLATION; ENZYME SPECIFICITY; ENZYME SYNTHESIS; GOLGI COMPLEX; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID COMPOSITION; LIPID DEGRADATION; LIPID HYDROLYSIS; LIPID STORAGE; LIPIDOSIS; NIEMANN PICK DISEASE; PH; PRIORITY JOURNAL; PROTEIN CONFORMATION; SECRETORY PATHWAY; STORAGE DISEASE; TAY SACHS DISEASE;

ANIMALS; HUMANS; SPHINGOLIPIDOSES;

EID: 84887928747     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20130083     Document Type: Conference Paper

References (52)

1. Breiden, B. and Sandhoff, K. (2013) The role of sphingolipid metabolism in cutaneous permeability barrier formation. Biochim. Biophys. Acta, doi: 10.1016/j.bbalip.2013.08.010
2. Sandhoff, R. (2010) Very long chain sphingolipids: tissue expression, function and synthesis. FEBS Lett. 584, 1907-1913
3. Jennemann, R., Rabionet, M., Gorgas, K., Epstein, S., Dalpke, A., Rothermel, U., Bayerle, A., van der Hoeven, F., Imgrund, S., Kirsch, J. et al. (2012) Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum. Mol. Genet. 21, 586-608
4. Levy, M. and Futerman, A.H. (2010) Mammalian ceramide synthases. IUBMB Life 62, 347-356
5. Kolter, T. and Sandhoff, K. (1999) Sphingolipids: their metabolic pathways and the pathobiochemistry of neurodegenerative diseases. Angew. Chem. Int. Ed. 38, 1532-1568
6. Kolter, T., Proia, R.L. and Sandhoff, K. (2002) Combinatorial ganglioside biosynthesis. J. Biol. Chem. 277, 25859-25862
7. Proia, R.L. (2003) Glycosphingolipid functions: insights from engineered mouse models. Philos. Trans. R. Soc. London Ser. B 358, 879-883
8. Simpson, M.A., Cross, H., Proukakis, C., Priestman, D.A., Neville, D.C., Reinkensmeier, G., Wang, H., Wiznitzer, M., Gurtz, K., Verganelaki, A. et al. (2004) Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat. Genet. 36, 1225-1229
9. Penno, A., Reilly, M.M., Houlden, H., Laura, M., Rentsch, K., Niederkofler, V., Stoeckli, E.T., Nicholson, G., Eichler, F., Brown, Jr, R.H. et al. (2010) Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J. Biol. Chem. 285, 11178-11187
10. Fragaki, K., Ait-El-Mkadem, S., Chaussenot, A., Gire, C., Mengual, R., Bonesso, L., Beneteau, M., Ricci, J.E., Desquiret-Dumas, V., Procaccio, V. et al. (2012) Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency. Eur. J. Hum. Genet. 21, 528-534
11. Kacher, Y. and Futerman, A.H. (2006) Genetic diseases of sphingolipid metabolism: pathological mechanisms and therapeutic options. FEBS Lett. 580, 5510-5517
12. Kolter, T. and Sandhoff, K. (2006) Sphingolipid metabolism diseases. Biochim. Biophys. Acta 1758, 2057-2079
13. Vitner, E.B., Platt, F.M. and Futerman, A.H. (2010) Common and uncommon pathogenic cascades in lysosomal storage diseases. J. Biol. Chem. 285, 20423-20427
14. Schulze, H. and Sandhoff, K. (2011) Lysosomal lipid storage diseases. Cold Spring Harbor Perspect. Biol. 3, 287-305
15. Florey, O. and Overholtzer, M. (2012) Autophagy proteins in macroendocytic engulfment. Trends Cell Biol. 22, 374-380
16. Kolter, T. and Sandhoff, K. (2005) Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu. Rev. Cell Dev. Biol. 21, 81-103
17. Burkhardt, J.K., Huttler, S., Klein, A., Mobius, W., Habermann, A., Griffiths, G. and Sandhoff, K. (1997) Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor. Eur. J. Cell Biol. 73, 10-18
18. Mobius, W., Herzog, V., Sandhoff, K. and Schwarzmann, G. (1999) Intracellular distribution of a biotin-labeled ganglioside, GM1, by immunoelectron microscopy after endocytosis in fibroblasts. J. Histochem. Cytochem. 47, 1005-1014
19. Wollert, T. and Hurley, J.H. (2010) Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature 464, 864-869
20. Gallala, H.D., Breiden, B. and Sandhoff, K. (2011) Regulation of the NPC2 protein-mediated cholesterol trafficking by membrane lipids. J. Neurochem. 116, 702-707
21. Abdul-Hammed, M., Breiden, B., Adebayo, M.A., Babalola, J.O., Schwarzmann, G. and Sandhoff, K. (2010) Role of endosomal membrane lipids and NPC2 in cholesterol transfer and membrane fusion. J. Lipid Res. 51, 1747-1760
22. Gallala, H. and Sandhoff, K. (2011) Biological function of the cellular lipid BMP: BMP as a key activator for cholesterol sorting and membrane digestion. Neurochem. Res. 36, 1594-1600
23. Appelqvist, H., Sandin, L., Bjornstrom, K., Saftig, P., Garner, B., Ollinger, K. and Kagedal, K. (2012) Sensitivity to lysosome-dependent cell death is directly regulated by lysosomal cholesterol content. PLoS ONE 7, e50262
24. Giehl, A., Lemm, T., Bartelsen, O., Sandhoff, K. and Blume, A. (1999) Interaction of the GM2-activator protein with phospholipid-ganglioside bilayer membranes and with monolayers at the air-water interface. Eur. J. Biochem. 261, 650-658
25. Kolter, T. and Sandhoff, K. (2010) Lysosomal degradation of membrane lipids. FEBS Lett. 584, 1700-1712
26. Kolter, T., Winau, F., Schaible, U.E., Leippe, M. and Sandhoff, K. (2005) Lipid-binding proteins in membrane digestion, antigen presentation, and antimicrobial defense. J. Biol. Chem. 280, 41125-41128
27. Doering, T., Holleran, W.M., Potratz, A., Vielhaber, G., Elias, P.M., Suzuki, K. and Sandhoff, K. (1999) Sphingolipid activator proteins are required for epidermal permeability barrier formation. J. Biol. Chem. 274, 11038-11045
28. Kwon, H.J., Abi-Mosleh, L., Wang, M.L., Deisenhofer, J., Goldstein, J.L., Brown, M.S. and Infante, R.E. (2009) Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell 137, 1213-1224
29. Storch, J. and Xu, Z. (2009) Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking. Biochim. Biophys. Acta 1791, 671-678
30. Babalola, J.O., Wendeler, M., Breiden, B., Arenz, C., Schwarzmann, G., Locatelli-Hoops, S. and Sandhoff, K. (2007) Development of an assay for the intermembrane transfer of cholesterol by Niemann-Pick C2 protein. Biol. Chem. 388, 617-626
31. Vanier, M. (1983) Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen. Biochim. Biophys. Acta 750, 178-184
32. Zhou, S., Davidson, C., McGlynn, R., Stephney, G., Dobrenis, K., Vanier, M.T. and Walkley, S.U. (2011) Endosomal/lysosomal processing of gangliosides affects neuronal cholesterol sequestration in Niemann-Pick disease type C. Am. J. Pathol. 179, 890-902
33. Locatelli-Hoops, S., Remmel, N., Klingenstein, R., Breiden, B., Rossocha, M., Schoeniger, M., Koenigs, C., Saenger, W. and Sandhoff, K. (2006) Saposin A mobilizes lipids from low cholesterol and high bis(monoacylglycerol)phosphate- containing membranes: patient variant saposin A lacks lipid extraction capacity. J. Biol. Chem. 281, 32451-32460
34. Remmel, N., Locatelli-Hoops, S., Breiden, B., Schwarzmann, G. and Sandhoff, K. (2007) Saposin B mobilizes lipids from cholesterol-poor and bis(monoacylglycero)phosphate-rich membranes at acidic pH: unglycosylated patient variant saposin B lacks lipid-extraction capacity. FEBS J. 274, 3405-3420
35. Kytzia, H.J., Hinrichs, U., Maire, I., Suzuki, K. and Sandhoff, K. (1983) Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity. EMBO J. 2, 1201-1205
36. Mehl, E. and Jatzkewitz, H. (1964) Eine Cerebrosidsulfatase aus Schweineniere. Hoppe-Seyler's Z. Physiol. Chem. 339, 260-276
37. Stevens, R.L., Fluharty, A.L., Kihara, H., Kaback, M.M., Shapiro, L.J., Marsh, B., Sandhoff, K. and Fischer, G. (1981) Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy. Am. J. Hum. Genet. 33, 900-906
38. Gartner, S., Conzelmann, E. and Sandhoff, K. (1983) Activator protein for the degradation of globotriaosylceramide by human α-galactosidase. J. Biol. Chem. 258, 12378-12385
39. Sun, Y., Witte, D.P., Ran, H., Zamzow, M., Barnes, S., Cheng, H., Han, X., Williams, M.T., Skelton, M.R., Vorhees, C.V. and Grabowski, G.A. (2008) Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice. Hum. Mol. Genet. 17, 2345-2356
40. Li, S.C., Sonnino, S., Tettamanti, G. and Li, Y.T. (1988) Characterization of a nonspecific activator protein for the enzymatic hydrolysis of glycolipids. J. Biol. Chem. 263, 6588-6591
41. Wendeler, M., Hoernschemeyer, J., John, M., Werth, N., Schoeniger, M., Lemm, T., Hartmann, R., Kessler, H. and Sandhoff, K. (2004) Expression of the GM2-activator protein in the methylotrophic yeast Pichia pastoris, purification, isotopic labeling, and biophysical characterization. Protein Expression Purif. 34, 147-157
42. Wilkening, G., Linke, T., Uhlhorn-Dierks, G. and Sandhoff, K. (2000) Degradation of membrane-bound ganglioside GM1: stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP. J. Biol. Chem. 275, 35814-35819
43. Werth, N., Schuette, C.G., Wilkening, G., Lemm, T. and Sandhoff, K. (2001) Degradation of membrane-bound ganglioside GM2 by β-hexosaminidase A: stimulation by GM2 activator protein and lysosomal lipids. J. Biol. Chem. 276, 12685-12690
44. Wilkening, G., Linke, T. and Sandhoff, K. (1998) Lysosomal degradation on vesicular membrane surfaces: enhanced glucosylceramide degradation by lysosomal anionic lipids and activators. J. Biol. Chem. 273, 30271-30278
45. Linke, T., Wilkening, G., Sadeghlar, F., Mozcall, H., Bernardo, K., Schuchman, E. and Sandhoff, K. (2001) Interfacial regulation of acid ceramidase activity: stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins. J. Biol. Chem. 276, 5760-5768
46. Sandhoff, K. (2012) My journey into the world of sphingolipids and sphingolipidoses. Proc. Jpn. Acad., Ser. B 88, 554-582
47. Conzelmann, E. and Sandhoff, K. (1983) Partial enzyme deficiencies: residual activities and the development of neurological disorders. Dev. Neurosci. 6, 58-71
48. Leinekugel, P., Michel, S., Conzelmann, E. and Sandhoff, K. (1992) Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum. Genet. 88, 513-523
49. Graber, D., Salvayre, R. and Levade, T. (1994) Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells. J. Neurochem. 63, 1060-1068
50. Meivar-Levy, I., Horowitz, M. and Futerman, A.H. (1994) Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-d- erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease. Biochem. J. 303, 377-382
51. Wright, C.S., Zhao, Q. and Rastinejad, F. (2003) Structural analysis of lipid complexes of GM2-activator protein. J. Mol. Biol. 331, 951-964
52. Wendeler, M., Hoernschemeyer, J., Hoffmann, D., Kolter, T., Schwarzmann, G. and Sandhoff, K. (2004) Photoaffinity labelling of the human GM2-activator protein. Eur. J. Biochem. 271, 614-627